Stent

Among patients who had endovascular revascularization of the superficial femoral artery, stent thrombosis occurred in more than 7% of patients, with a 5-year probability of more than 13%, researchers reported.

B. Braun Interventional Systems announced that a drug-coated balloon catheter for percutaneous transluminal coronary angioplasty has received a breakthrough device designation from the FDA for the treatment of patients with coronary in-stent restenosis.